People and Partners
PharmaFutures is managed and facilitate by Meteos, a non-profit company specialising in cross-sector dialogue and innovation. Meet the Meteos team.
The participants in the different phases of PharmaFutures have been determined by the subject matter under discussion.
There has been considerable overlap, with some participants being active throughout the whole process.
The European Participants in the current PharmaFutures project can be seen below:
- Mr Stewart Adkins, Stewart Adkins Advisors Ltd, Director
- Mr Mark Becker, Healthcare Analyst, Fidelity International
- Dr Rafael Bengoa, Minister for Health and Consumer Affairs in the Basque Country, Basque Government
- Dr Scott Braunstein, Managing Director, JP Morgan Asset Management
- Dr Anna Bucsics, Vice Department Head, Department of Pharmaceuticals, Association of Austrian Social Security Institutions
- Dr Angela Coulter, Director of Global Initiatives, Foundation for Informed Medical Decision-making
- Mr Jim Easton, National Director for Improvement and Efficiency, UK Department of Health
- Mr Joel Emery, Independent
- Ms Charlotte Ersbøll, Corporate Vice President, Global Stakeholder Engagement, Novo Nordisk
- Mr Eddie Gray, President, Pharmaceuticals Europe, Glaxo SmithKline
- Dr Jane Griffiths, Company Group Chairman, Janssen Pharmaceuticals EMEA, Johnson & Johnson
- Mr Graham Hetherington, Chief Financial Officer, Shire plc
- Mr Thomas Heynisch, Deputy Head of Unit, DG Enerprise and Industry, European Commission
- Mr Simon Jose, President of Stiefel, Glaxo SmithKline
- Ms Natasha Landell-Mills, Senior Analyst, USS
- Valerie Paris, Head of Healthcare Policy, OECD
- Prof Sir Michael Rawlins, Chariman, NICE
- Dr Jack Scannell, Analyst, Stanford C. Bernstein & Co., LLC
- Mr John Schaetzl, Industry Commentator, Independent
- Dr Ad Schuurman, President, MEDEV
- Mr Carl Seiden, President, Seiden Pharmaceutical Strategies
- Dr Divya Srivastava, Health Economist, OECD
- Mr Dan Summerfield, Co-Head Responsible Investment, USS
- Dr Giorgia Valsesia, Healthcare Analyst, SAM Research AG
- Mr Stijn Vanacker, Analyst Global Healthcare, Robeco
- Mr Bo Wesley, Senior Specialist, Innovation and Effectiveness, Novo Nordisk
The participants for the earlier PharmaFutures Workshops can be found below:
Comments
This is such a vital industry, with a strong and complex social contract. Hopefully, PharmaFutures can contribute to improved communications and a better alignment between society and shareholder needs.
Sophia Tickell, Director of PharmaFutures